Halothane-induced calcium release in cultured human skeletal muscle cells from a family susceptible to malignant hyperthermia with an unidentified mutation in chromosome 19

Anesthesiology

Volumn 97, Issue 1, 2002, Pages 272-274

  Snoeck, Marc M ^a   Oosterhof, Arie ^a   Tangerman, Albert ^a   Veerkamp, Jacques H ^a   Van Engelen, Baziel G ^a   Gielen, Mathieu J ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HALOTHANE;

ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CHROMOSOME 19; CHROMOSOME MUTATION; CONTROLLED STUDY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MALIGNANT HYPERTHERMIA; MUSCLE BIOPSY; PRIORITY JOURNAL;

CALCIUM; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 19; DISEASE SUSCEPTIBILITY; HALOTHANE; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE, SKELETAL; MUTATION;

EID: 0036306353     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200207000-00038     Document Type: Article

References (17)

1. Minireview: The biochemistry of malignant hyperthermia: Recent concepts
2. Genetics and pathogenesis of malignant hyperthermia
3. Identification of a mutation in the porcine ryanodine receptor that is associated with malignant hyperthermia
4. Identification of novel mutations in the ryanodine receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation
5. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia
6. Metabolic error of muscle metabolism after recovery from malignant hyperthermia
7. Halothane-induced muscle contracture as a cause of hyperpyrexia
8. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects
9. Standardization of the caffeine halothane muscle contracture test
10. 2+ and excitability
11. 2+ homeostasis in Brody's disease
12. A new generation of Ca2+ indicators with greatly improved fluorescence properties
13. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane
14. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals
15. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes
16. 2+ release channels
17. The point mutation Arg615Cys in Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia